Trial Profile
Phase 1 Does-escalation Study of Oral SKI-606 in Subjects With Advanced Malignant Solid Tumors.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Dec 2009
Price :
$35
*
At a glance
- Drugs Bosutinib (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Wyeth
- 06 Nov 2009 New trial record